Get the Stockscreener App
1.0205
1.04%
0.0105
Clearmind Medicine Inc stock is traded at $1.0205, with a volume of 24,995.
It is up +1.04% in the last 24 hours and up +4.13% over the past month.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
See More
Previous Close:
$1.01
Open:
$1.01
24h Volume:
24,995
Relative Volume:
0.03
Market Cap:
$4.35M
Revenue:
-
Net Income/Loss:
$-6.78M
P/E Ratio:
-0.0239
EPS:
-42.6996
Net Cash Flow:
$-4.67M
1W Performance:
+0.05%
1M Performance:
+4.13%
6M Performance:
-10.48%
1Y Performance:
-19.01%
1-Day Range:
$1.01
$1.03
1-Week Range:
$1.01
$1.0798
52-Week Range:
$0.80
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
1.0205 | 5.59M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearmind Medicine Inc Stock (CMND) Latest News
What does recent volatility data suggest for Clearmind Medicine Inc.Inflation Watch & Fast Entry Momentum Alerts - Newser
Can Clearmind Medicine Inc. scale operations efficientlyJuly 2025 Decliners & Fast Moving Stock Watchlists - khodrobank.com
How moving averages guide Clearmind Medicine Inc. tradingEntry Point & Low Risk Entry Point Tips - Newser
Clearmind Medicine (NASDAQ:CMND) versus Aquestive Therapeutics (NASDAQ:AQST) Head to Head Contrast - Defense World
What is Clearmind Medicine Inc. s revenue forecast2025 Price Momentum & Technical Confirmation Trade Alerts - khodrobank.com
Heatmap analysis for Clearmind Medicine Inc. and competitorsPortfolio Return Summary & Capital Protection Trade Alerts - Newser
Clearmind Medicine Inc. stock daily chart insights2025 Top Decliners & Verified Swing Trading Watchlist - Newser
Volume spikes in Clearmind Medicine Inc. stock – what they mean2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
Is it too late to sell Clearmind Medicine Inc.July 2025 Spike Watch & Growth Focused Stock Reports - Newser
Can Clearmind Medicine Inc. maintain sales growthJuly 2025 Recap & AI Powered Market Entry Strategies - khodrobank.com
Retail Trends: What’s the analyst consensus on Clearmind Medicine Inc.Market Performance Recap & Technical Confirmation Alerts - khodrobank.com
Is Clearmind Medicine Inc. currently under institutional pressureJuly 2025 Retail & Free Technical Pattern Based Buy Signals - khodrobank.com
Will Clearmind Medicine Inc. stock go up soon2025 Year in Review & Fast Entry High Yield Stock Tips - Newser
Is Clearmind Medicine Inc. trending in predictive chart models2025 AllTime Highs & Weekly Top Gainers Trade List - Newser
What MACD and RSI say about Clearmind Medicine Inc.July 2025 Pullbacks & High Conviction Buy Zone Alerts - Newser
Is Clearmind Medicine Inc. stock poised for growthTrade Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Regression analysis insights on Clearmind Medicine Inc. performanceMarket Movement Recap & Safe Entry Zone Identification - Newser
What recovery options are there for Clearmind Medicine Inc.Market Growth Summary & Consistent Profit Focused Trading Strategies - Newser
Analyzing drawdowns of Clearmind Medicine Inc. with statistical toolsEarnings Risk Summary & Real-Time Price Movement Reports - Newser
Technical Bounce Expected in Clearmind Medicine Inc. Next Week2025 Analyst Calls & Capital Protection Trade Alerts - beatles.ru
Will Clearmind Medicine Inc. benefit from green energy policiesQuarterly Portfolio Report & Smart Allocation Stock Tips - khodrobank.com
Analyzing Clearmind Medicine Inc. with multi timeframe charts2025 Volatility Report & Weekly Hot Stock Watchlists - Newser
Tools to monitor Clearmind Medicine Inc. recovery probability2025 Macro Impact & AI Powered Market Trend Analysis - Newser
Is Clearmind Medicine Inc. showing signs of accumulationGlobal Markets & Stock Timing and Entry Methods - Newser
Is Clearmind Medicine Inc. subject to activist investor interestMarket Performance Report & High Conviction Buy Zone Alerts - khodrobank.com
Clearmind Medicine (NASDAQ:CMND) vs. Vaxart (NASDAQ:VXRT) Critical Contrast - Defense World
Investment Report: Is Clearmind Medicine Inc. currently under institutional pressureJuly 2025 Price Swings & Low Drawdown Trading Strategies - khodrobank.com
Recovery Signals Appearing in Clearmind Medicine Inc. Charts getLinesFromResByArray error: size == 0 - 강소기업뉴스
Clearmind Medicine Inc. stock outlook for YEAR2025 Price Targets & Safe Entry Point Identification - Newser
Trendlines Suggest Clearmind Medicine Inc. May Bottom Out Soon getLinesFromResByArray error: size == 0 - classian.co.kr
Trend analysis for Clearmind Medicine Inc. this week2025 Risk Factors & Reliable Momentum Entry Alerts - Newser
Analyzing net buyer seller activity in Clearmind Medicine Inc.2025 Analyst Calls & High Return Stock Watch Alerts - Newser
Clearmind Medicine Inc. Stages Intraday Comeback — Trend ChangePortfolio Gains Report & Stock Portfolio Risk Management - beatles.ru
Clearmind Medicine Inc. stock trendline breakdownJuly 2025 Summary & Daily Technical Stock Forecast Reports - Newser
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):